IMHO, SDX was a reverse-takeover, the current board 'direction' isn't necessarily completely-aligned to realising SH-value for 'all' SH (us), just the select few that are of the firm belief that the Sub2M/EXONET streams offer more 'opportunity' (think LTI, STI KPI-targets embedded into merger-terms, etc) than the BARD1 (Aab) stream, noting that there is still 'highly-contentious' litigation brewing in the background...
As I've suggested, I suspect there some 'very big EGO's' stepped aboard during the SDX/BD1 merger, founding directors/scientists don't 'walk-away' from their 'life's work' for nothing, as we're observing (although without much transparency, despite disclosure obligations)...
More BD1 (Aab) patents to poke a stick at to protect a work-stream they've 'starved' of CAPEX for their own 'perceived' interests, I won't be re-electing any of the current directors without some form of transparency around why/how (NPV, ROI, TCO, etc) they 'allocate' CAPEX to work-streams...
To me, something doesn't quite seem 100% right, bit grubby...
Ann: Brazilian Patent Issued for Lung & Colorectal Cancer, page-3
-
- There are more pages in this discussion • 19 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IIQ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
62.5¢ |
Change
0.050(8.70%) |
Mkt cap ! $65.94M | |||
| Open | High | Low | Value | Volume |
| 57.5¢ | 63.0¢ | 57.5¢ | $117.5K | 196.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1000 | 59.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 62.5¢ | 2484 | 2 |
View Market Depth
| Last trade - 16.10pm 05/07/2024 (20 minute delay) ? |
| IIQ (ASX) Chart |